Evaluation of immunotherapy in the treatment of melanoma

Surgical Oncology Clinics of North America
Mark B Faries

Abstract

These data show that the extraordinary potency of the immune system can be harnessed to control or destroy melanoma. The proven impact has been limited for patients who have melanoma, but has been dramatic and lasting in selected groups. Recent improvements in understanding of immunology, including mechanisms regulating immune responses and methods of tumor cell escape, are already yielding improved clinical outcomes and potential avenues for extending benefits to more patients. Thus, although the full potential of this treatment modality has yet to be realized, the vanguard of the "treatment of tomorrow" has clearly arrived.

References

Jan 29, 1976·The New England Journal of Medicine·F R EilberK P Ramming
Jan 1, 1992·Annals of Plastic Surgery·S D ScogginM K Wallack
Dec 20, 1989·Journal of the National Cancer Institute·W H ClarkA C Halpern
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A N HoughtonL J Old
Jan 1, 1980·Annals of Surgery·A E GiulianoD L Morton
Jul 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·L TafraD L Morton
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Aug 3, 1994·Journal of the National Cancer Institute·S A RosenbergD E White
Sep 1, 1996·Archives of Surgery·D W OllilaD L Morton
Apr 10, 1997·International Journal of Cancer. Journal International Du Cancer·E JägerA Knuth
Aug 1, 1997·Melanoma Research·M L NasiP B Chapman
Aug 15, 1998·Journal of the American College of Surgeons·E C HsuehD L Morton
Aug 26, 1998·The American Journal of Surgical Pathology·K J BusamA A Jungbluth
Sep 2, 1998·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·T S WangT M Johnson
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·G ZengR F Wang
Oct 31, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·L RidolfiM G Righini
Feb 5, 2002·Clinical Oncology : a Journal of the Royal College of Radiologists·M KingD C Rowlands
Mar 22, 2002·Nature Reviews. Immunology·W R Heath, F R Carbone
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vernon K SondakLawrence E Flaherty
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey A SosmanUNKNOWN Southwest Oncology Group
Jun 12, 2002·Archives of Dermatology·Lori K E RodriguesMohammed Kashani-Sabet
Jun 12, 2002·Current Treatment Options in Oncology·V K SondakL M Schuchter
Oct 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter HerseyR John Simes
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mathew H ChungDonald L Morton
Feb 7, 2003·The New England Journal of Medicine·Rona M MacKieBrian Junor
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Isabelle BedrosianBrian J Czerniecki
Dec 24, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David BerdMichael J Mastrangelo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Nature Reviews. Immunology
Gemma K Alderton, Yvonne Bordon
Current Opinion in Immunology
Karolina PaluckaJacques Banchereau
Seminars in Immunopathology
Monique Gannage, Christian Münz
© 2022 Meta ULC. All rights reserved